Medical Daily

• Keytruda Wins Full FDA Approval for High-Mutation Tumors, but a Stricter Cutoff Could Narrow Who Qualifies
  Keytruda now has full FDA approval for TMB-high tumors, but the cutoff rose from 10 to 13 mutations per megabase. What cancer patients should ask.
• India-Made Toothpaste Recalls Topped 4 Million Units Twice in Under 18 Months as Kids' Brands Join the List
  A 4.3 million-tube toothpaste recall follows a 2025 recall of 4.6 million units, both from Indian makers. What parents should know about oversight.